Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1069302.RAgR1LK4TqOi45X9S1_4HGvmFRkgf9c4Uub_9YgicP7k8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1069302.RAgR1LK4TqOi45X9S1_4HGvmFRkgf9c4Uub_9YgicP7k8130_assertion type Assertion NP1069302.RAgR1LK4TqOi45X9S1_4HGvmFRkgf9c4Uub_9YgicP7k8130_head.
- NP1069302.RAgR1LK4TqOi45X9S1_4HGvmFRkgf9c4Uub_9YgicP7k8130_assertion description "[These observations suggest that icotinib-induced upregulation of Cbl-b is responsible, at least in part, for the antitumor effect of icotinib via the inhibition of phosphoinositide 3-kinase (PI3K)/Akt and mitogen-activated protein kinase pathways in EGFR-mutated NSCLC cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069302.RAgR1LK4TqOi45X9S1_4HGvmFRkgf9c4Uub_9YgicP7k8130_provenance.
- NP1069302.RAgR1LK4TqOi45X9S1_4HGvmFRkgf9c4Uub_9YgicP7k8130_assertion evidence source_evidence_literature NP1069302.RAgR1LK4TqOi45X9S1_4HGvmFRkgf9c4Uub_9YgicP7k8130_provenance.
- NP1069302.RAgR1LK4TqOi45X9S1_4HGvmFRkgf9c4Uub_9YgicP7k8130_assertion SIO_000772 23586056 NP1069302.RAgR1LK4TqOi45X9S1_4HGvmFRkgf9c4Uub_9YgicP7k8130_provenance.
- NP1069302.RAgR1LK4TqOi45X9S1_4HGvmFRkgf9c4Uub_9YgicP7k8130_assertion wasDerivedFrom befree-2016 NP1069302.RAgR1LK4TqOi45X9S1_4HGvmFRkgf9c4Uub_9YgicP7k8130_provenance.
- NP1069302.RAgR1LK4TqOi45X9S1_4HGvmFRkgf9c4Uub_9YgicP7k8130_assertion wasGeneratedBy ECO_0000203 NP1069302.RAgR1LK4TqOi45X9S1_4HGvmFRkgf9c4Uub_9YgicP7k8130_provenance.